Neuland Laboratories Ltd (NEULANDLAB) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 229993, "name": "Neuland Labs.", "stock_name": "Neuland Labs.", "full_name": "Neuland Laboratories Ltd", "name_url": "stocks-analysis/neuland-labs", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "17,693.65", "chg": 393.2, "chgp": "2.27%", "dir": 1, "prev_price": "17,300.45", "mcapval": "22,386.00 Cr", "mcap": "Small Cap", "scripcode": 524558, "symbol": "NEULANDLAB", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE794A01010", "curr_date": "May 08", "curr_time": "", "bse_nse_vol": "94.81 k", "exc_status": "Active", "traded_date": "May 08, 2026", "traded_date_str": "2026 05 08", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/neuland-labs-229993-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Neuland Laboratories Ltd Upgraded to Hold as Technicals Improve Despite Financial Challenges", "link": "https://www.marketsmojo.com/news/stock-recommendation/neuland-laboratories-ltd-upgraded-to-hold-as-technicals-improve-despite-financial-challenges-3977070", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NeulandLaborato_mojoScore_3977070.png", "date": "2026-05-06 08:07:02", "description": "Neuland Laboratories Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced shift in its technical outlook and institutional backing despite recent financial headwinds. The upgrade is driven primarily by improved technical indicators, stable quality metrics, and a cautious valuation stance amid mixed financial trends." }, { "title": "Neuland Laboratories Ltd Technical Momentum Shifts Signal Mildly Bullish Outlook", "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-ltd-technical-momentum-shifts-signal-mildly-bullish-outlook-3976724", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NeulandLaborato_technicaldot_3976724.png", "date": "2026-05-06 08:00:38", "description": "Neuland Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, suggesting cautious optimism among investors as the stock navigates current market conditions." }, { "title": "Neuland Laboratories Ltd Sees Technical Momentum Shift Amid Strong Price Rally", "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-ltd-sees-technical-momentum-shift-amid-strong-price-rally-3974628", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NeulandLaborato_technicaldot_3974628.png", "date": "2026-05-05 08:00:58", "description": "Neuland Laboratories Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of bullish and bearish signals across key indicators. Despite a strong day change of 7.58%, the stock’s technical landscape remains nuanced, with mixed signals from MACD, RSI, moving averages, and other momentum indicators suggesting cautious optimism for investors." }, { "title": "Neuland Laboratories Ltd Surges 7.09% to Day's High of Rs 16,460 — Outperforms Sector by 5.81 Percentage Points", "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-ltd-hits-intraday-high-with-709-surge-on-4-may-2026-3974037", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NeulandLaborato_priceRelatedfactors_3974037.png", "date": "2026-05-04 11:45:48", "description": "The Sensex advanced 0.99% on 4 May 2026, yet Neuland Laboratories Ltd outpaced the broader market with a 7.09% gain, reaching an intraday high of Rs 16,460. This 5.81-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific momentum shift rather than a mere market tailwind." }, { "title": "Neuland Laboratories Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/neuland-laboratories-ltd-is-rated-sell-3968028", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/NeulandLaborato_mojoScore_3968028.png", "date": "2026-04-29 10:10:53", "description": "Neuland Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 April 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Neuland Laboratories Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/neuland-laboratories-ltd-is-rated-sell-3951916", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/NeulandLaborato_mojoScore_3951916.png", "date": "2026-04-18 10:10:38", "description": "Neuland Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 April 2026, providing investors with an up-to-date perspective on the company’s performance and outlook." }, { "title": "Neuland Laboratories Gains 13.03%: 4 Key Factors Driving This Week’s Rally", "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-gains-1303-4-key-factors-driving-this-weeks-rally-3943591", "imagepath": "", "date": "2026-04-12 13:00:04", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>6 Apr:</strong> Intraday high of Rs.13,464 with 7.15% surge</p>\n <p><strong>7 Apr:</strong> Mojo Score upgraded to Sell from Strong Sell</p>\n <p><strong>8 Apr:</strong> Intraday high of Rs.14,077.3 with 7.33% surge</p>\n <p><strong>10 Apr:</strong> Week closes at Rs.14,948.95, up 13.03%</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.13,225.55</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.14,948.95</div><div class=\"stat-chan..." }, { "title": "Neuland Laboratories Ltd Surges 7.33% to Day's High of Rs 14077.3 — Outperforms Sector by 6.06 Percentage Points", "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-ltd-hits-intraday-high-with-733-surge-on-8-april-2026-3938006", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/NeulandLaborato_priceRelatedfactors_3938006.png", "date": "2026-04-08 15:30:44", "description": "The Sensex advanced 4.03% on 8 Apr 2026, yet Neuland Laboratories Ltd outpaced the broader market with a 7.33% gain, reaching an intraday high of Rs 14,077.3. This 6.06-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific momentum shift rather than a mere market tailwind." }, { "title": "Neuland Laboratories Ltd Upgraded to Sell on Technical Improvements Despite Financial Challenges", "link": "https://www.marketsmojo.com/news/stock-recommendation/neuland-laboratories-ltd-upgraded-to-sell-on-technical-improvements-despite-financial-challenges-3935682", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/NeulandLaborato_mojoScore_3935682.png", "date": "2026-04-07 08:10:32", "description": "Neuland Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell, reflecting a nuanced shift driven primarily by technical indicators, even as fundamental financial metrics continue to pose concerns. The company’s recent performance across quality, valuation, financial trends, and technicals has prompted analysts to revise their outlook, balancing cautious optimism with persistent challenges in profitability and growth." } ], "total": 759, "sid": "229993", "stock_news_url": "https://www.marketsmojo.com/news/neuland-laboratories-229993" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation", "datetime": "29-Apr-2026", "details": "Q4FY26 Earnings Call Intimation", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "21-Apr-2026", "details": "Newspaper advertisement of Notice for transferring unclaimed dividend and underlying equity shares to IEPF", "source": "BSE" }, { "caption": "Board Meeting Intimation for Considering And Approving The Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Financial Year Ended March 31 2026 And; To Recommend Final Dividend If Any For The Financial Year Ended Mar", "datetime": "20-Apr-2026", "details": "Neuland Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2026 inter alia to consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended March 31 2026 and; to recommend final dividend if any for the financial year ended March 31 2026", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "", "data": [ { "title": "BOARD MEETING", "txt": "12 May 2026" } ] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Neuland Laboratories Ltd has declared <strong>120%</strong> dividend, ex-date: 18 Jul 25", "dt": "2025-07-18", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "", "data": [ { "txt": "Neuland Laboratories Ltd has announced <strong>4:25</strong> rights issue, ex-date: 13 Aug 14", "dt": "2014-08-13", "middle_text": "Rights Issue" } ] } ] }

Key Events This Week

6 Apr: Intraday high of Rs.13,464 with 7.15% surge

7 Apr: Mojo Score upgraded to Sell from Strong Sell

8 Apr: Intraday high of Rs.14,077.3 with 7.33% surge

10 Apr: Week closes at Rs.14,948.95, up 13.03%

Read full news article

Neuland Laboratories Ltd Surges 7.33% to Day's High of Rs 14077.3 — Outperforms Sector by 6.06 Percentage Points

2026-04-08 15:30:44

The Sensex advanced 4.03% on 8 Apr 2026, yet Neuland Laboratories Ltd outpaced the broader market with a 7.33% gain, reaching an intraday high of Rs 14,077.3. This 6.06-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific momentum shift rather than a mere market tailwind.

Read full news article

Neuland Laboratories Ltd Upgraded to Sell on Technical Improvements Despite Financial Challenges

2026-04-07 08:10:32

Neuland Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell, reflecting a nuanced shift driven primarily by technical indicators, even as fundamental financial metrics continue to pose concerns. The company’s recent performance across quality, valuation, financial trends, and technicals has prompted analysts to revise their outlook, balancing cautious optimism with persistent challenges in profitability and growth.

Read full news article